Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North West London Pathology is a large NHS laboratory diagnostics network in London that provides pathology testing and related diagnostic services rather than developing therapeutic drugs. It is a joint venture between Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, and The Hillingdon Hospitals NHS Foundation Trust, and is hosted by Imperial College Healthcare NHS Trust. The organization operates one of the UK’s larger integrated NHS pathology networks, offering services across areas such as cellular pathology, clinical biochemistry, microbiology, histopathology, and molecular pathology. NWLP is active in research, innovation, digital pathology and laboratory systems transformation, and collaborates with academic, NHS and industry partners in the London life sciences ecosystem. For a biotech analyst, this is best understood as an operating clinical diagnostics and pathology services organization, not a venture-backed therapeutics biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North West London.